Edwards Lifesciences Corp (EW)


Stay up to date

edwards lifesciences (nyse: ew) is the global leader in the science of heart valves and hemodynamic monitoring. driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that save and enhance lives. headquartered in irvine, california, edwards lifesciences has extensive operations in north america, europe, japan, latin america and asia and currently employs about 6,400 individuals worldwide. for us, helping patients is not a slogan – it's our life’s work. from developing devices that replace or repair a diseased heart valve to creating new technologies that monitor vital signs in the critical care setting, we help ensure that patients regain and even improve their quality of life.

Financial Statements

Key Info

  • Industry:
  • Sector:
  • CEO Name: Michael Mussallem

Key Statistics

  • Stock Price: $84.67
  • Dividend Yield: 0%
  • Market Capitalization: $51,735,599,177
  • Shares Outstanding: 601,926,692
  • Number of Employees: 11,921
  • Trailing 12-Month EPS: $2.3
  • Trailing 12-Month DPS: $0
  • Payout Ratio: 0.0%

Important Dates

  • Next Earnings Date: 2024-08-01
  • Next Ex-Dividend Date:

Price Trends

  • Current Stock Price: $84.67
  • 52-week high: $96.12
  • 52-week low: $60.57
  • 200-day moving average: $79.01
  • 50-day moving average: $91.18


  • 1-Month Price Return: -10.1%
  • 3-Month Price Return: 15.3%
  • 6-Month Price Return: 39.3%
  • 1-Year Price Return: -2.3%
  • 2-Year Price Return: -18.7%
  • 5-Year Price Return: 47.9%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast